NeuroCom International


Founded in 1984, NeuroCom®, a division of Natus® is the world leader in the development of computerized tools for the assessment and rehabilitation of patients with balance and mobility disorders. This leadership, maintained through our commitment to products with strong scientific/clinical justification, extends to the best product support in the industry, and continuous educational support related to clinical applications and business opportunities.

Dr. Lewis Nashner, through cooperative research programs conducted with colleagues at a number of academic institutions, developed the concepts and technology that are the basis for the company’s products. Computerized Dynamic Posturography (CDP) was developed initially with grant support from NASA to evaluate the effects of space flight on vestibular function and balance control in astronauts, and with later support from the National Institute of Health to study the effects of disease on balance and mobility functions.

Following the disablement model outlined by the World Health Organization (WHO)1, 2, NeuroCom assessment protocols provide clinicians with specific diagnostic information related to underlying impairments and the resultant functional limitations, complementing traditional site-of-lesion diagnostic information.

Today, these systems are used around the globe in a broad spectrum of medical disciplines including otolaryngology, neurology, physiatry, orthopedics, sports medicine, geriatrics and physical rehabilitation, and are used in the management strategies of a wide range of acute and chronic disorders. There are more than one thousand medical and academic institutions utilizing NeuroCom technology in the United States and abroad.


  1. World Health Organization (1999). ICDIH-2 International Classification of Function and Disability. Beta-2 draft. Short Version. Geneva, Switzerland.
  2. World Health Organization (1997). International Classification of Disease, 9th rev. Clinical Modification. New York, NY.